Form Bio Co. Ltd. (KQ:377220) — Stock Price

₩3330.00 KRW
▲ 549.12% today

Form Bio Co. Ltd. (KQ:377220) is currently trading at ₩3330.00 KRW, up 549.12% today. Over the past 52 weeks, shares have ranged between ₩513.00 and ₩3330.00. This page tracks Form Bio Co. Ltd.'s live share price on the KQ exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see Form Bio Co. Ltd. (377220) total market value.

Form Bio Co. Ltd. (377220) Stock Price Chart — Daily History & Trading Volume

The chart below tracks Form Bio Co. Ltd.'s daily closing share price and trading volume on the KQ exchange over the past year, giving a clear view of recent price momentum and liquidity.

Form Bio Co. Ltd. Income Statement — Revenue, Profit & Earnings by Year

Form Bio Co. Ltd.'s annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 20242023202220212020
Total Revenue ₩67.18 Billion ₩66.72 Billion ₩99.33 Billion ₩135.10 Billion ₩108.04 Billion
Cost of Revenue ₩30.04 Billion ₩20.77 Billion ₩30.02 Billion ₩33.00 Billion ₩23.03 Billion
Gross Profit ₩37.15 Billion ₩45.96 Billion ₩69.31 Billion ₩102.10 Billion ₩85.02 Billion
Research & Development — — — — —
SG&A ₩60.20 Billion ₩60.43 Billion ₩67.68 Billion ₩90.02 Billion ₩63.30 Billion
Total Operating Expenses ₩91.45 Billion ₩82.14 Billion ₩98.43 Billion ₩123.68 Billion ₩86.99 Billion
Operating Income ₩-24.41 Billion ₩-15.52 Billion ₩797.29 Million ₩11.34 Billion ₩19.94 Billion
EBITDA — — — — —
EBIT — — — — —
Interest Expense ₩1.02 Billion ₩188.65 Million ₩13.78 Million ₩24.70 Million ₩612.35 Million
Income Before Tax ₩-24.89 Billion ₩-15.74 Billion ₩1.51 Billion ₩11.64 Billion ₩-4.01 Billion
Income Tax Expense — — — — —
Net Income ₩-25.29 Billion ₩-11.08 Billion ₩3.24 Billion ₩11.28 Billion ₩-7.81 Billion

Form Bio Co. Ltd. Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes Form Bio Co. Ltd.'s financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 20242023202220212020
Total Assets ₩81.18 Billion ₩97.36 Billion ₩93.82 Billion ₩96.41 Billion ₩44.99 Billion
Total Current Assets ₩29.01 Billion ₩37.65 Billion ₩53.56 Billion ₩71.72 Billion ₩30.98 Billion
Cash & Equivalents — — ₩1.81 Billion ₩8.12 Billion ₩7.56 Billion
Short-term Investments ₩1.00 Billion — ₩25.00 Billion ₩35.98 Billion ₩5.00 Billion
Net Receivables ₩2.90 Billion ₩2.11 Billion ₩2.14 Billion ₩4.02 Billion ₩4.51 Billion
Inventory ₩19.56 Billion ₩25.47 Billion ₩22.07 Billion ₩20.93 Billion ₩11.45 Billion
Property, Plant & Equipment — — ₩33.31 Billion ₩20.33 Billion ₩12.51 Billion
Goodwill — — — — —
Total Liabilities ₩32.07 Billion ₩22.19 Billion ₩5.87 Billion ₩11.99 Billion ₩21.35 Billion
Total Current Liabilities ₩27.18 Billion ₩21.91 Billion ₩6.43 Billion ₩11.65 Billion ₩18.25 Billion
Long-term Debt ₩4.50 Billion — — ₩0.00 ₩2.32 Billion
Net Debt ₩24.33 Billion ₩11.96 Billion — — —
Total Stockholder Equity ₩50.24 Billion ₩76.64 Billion ₩87.96 Billion ₩84.43 Billion ₩23.64 Billion
Retained Earnings ₩-1.78 Billion ₩-26.49 Billion ₩-15.41 Billion ₩-18.65 Billion ₩-29.94 Billion

Form Bio Co. Ltd. Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how Form Bio Co. Ltd. generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 20242023202220212020
Operating Cash Flow ₩-14.70 Billion ₩-20.85 Billion ₩-2.02 Billion ₩-1.17 Billion ₩15.61 Billion
Capital Expenditures ₩893.42 Million ₩16.70 Billion ₩15.18 Billion ₩11.17 Billion ₩6.63 Billion
Free Cash Flow ₩-16.27 Billion ₩-37.54 Billion ₩-17.21 Billion ₩-12.35 Billion ₩8.98 Billion
Investing Cash Flow ₩2.60 Billion ₩7.33 Billion ₩-4.88 Billion ₩-42.09 Billion ₩-8.77 Billion
Financing Cash Flow ₩7.62 Billion ₩18.15 Billion ₩594.29 Million ₩43.83 Billion ₩-3.04 Billion
Dividends Paid — — — — —
Stock-Based Compensation — — — — ₩21.99 Million
Depreciation ₩2.20 Billion ₩1.56 Billion ₩920.15 Million ₩959.21 Million ₩846.96 Million
Change in Cash ₩-4.47 Billion ₩4.63 Billion ₩-6.31 Billion ₩565.48 Million ₩3.80 Billion

Form Bio Co. Ltd. Earnings History — EPS Actual vs. Analyst Estimates

Track Form Bio Co. Ltd.'s quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Report Date EPS Actual EPS Estimate Surprise
Sep 30, 2025 -166.90 — —
Jun 30, 2025 -155.46 — —
Mar 31, 2025 -95.80 — —
Dec 31, 2024 -421.30 — —
Sep 30, 2024 -156.73 — —
Jun 30, 2024 -100.25 — —
Mar 31, 2024 -214.98 — —
Dec 31, 2023 -139.44 — —